Clinical Trial Update: Study Investigating Tailored Treatment With Infliximab for Active Crohn's Disease [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating tailored infliximab treatment for active Crohn's disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Crohn Disease

Drugs mentioned

• Remicade (infliximab)

Snippet

Sponsor: Groupe d'Etude Therapeutique des Affections Inflammatoires Digestives | Conditions: Crohn's Disease | Phase 4 | Status: COMPLETED